A systematic review concluded that while bgenomic classifier (GC) tests/b could affect risk classifications or treatment choices for patients with

A systematic review found that while genomic classifier (GC) tests may influence risk classifications or treatment decisions for patients with...

TUESDAY, Jan. 21, 2025 -- For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk...

TUESDAY, Jan. 21, 2025 -- For patients with localized prostate cancer (PCa), tissue-based genomic classifiers (GCs) do not consistently influence risk...

Researchers conducted a review examining how three genomic tests-Decipher, Oncotype DX Genomic Prostate Score (GPS), and Prolaris-can aid doctors in...

Genomic tests are revolutionizing prostate cancer care, enabling precise, personalized treatment tailored to each patient.

A groundbreaking prostate cancer treatment has returned to WA after a lack of expertise in the State meant men had to travel to access the life-saving...

Biohacking is a rapidly growing movement that combines technology, biology, and self-experimentation to optimize human performance and well-being....

This article examines Bangladesh Nationalist Party's "31-Point Outline for Structural Reforms" through a critical analysis of its proposed...

By Dr Wilfred Wan and Dr Gitte du Plessis In July 2024 Norway’s Kongsberg Defence & Aerospace signed a contract with the Norwegian Defence...